AtheroGenics Gets Knocked Down
Drug developer AtheroGenics (AGIX) said Wednesday its failed heart-drug candidate showed signs it may be effective as an oral anti-diabetic drugThe company is currently recruiting patients for a Phase III ...Read Full Story »

